Key research presented at ASH 2010

Prof George Canellos - Harvard Medical School, Boston, USA
Key research presented at ASH 2010 ( Prof George Canellos - Harvard Medical School, Boston, USA )
21 Feb 2011

The role of comorbidity indices in the prognosis of elderly MDS patients

Prof Valeria Santini - University of Florence, Italy
The role of comorbidity indices in the prognosis of elderly MDS patients ( Prof Valeria Santini - University of Florence, Italy )
21 Feb 2011

Burkitt’s lymphoma in the elderly

Dr Antonio Pinto - Fondazione ‘G. Pascale’, Naples, Italy
Burkitt’s lymphoma in the elderly ( Dr Antonio Pinto - Fondazione ‘G. Pascale’, Naples, Italy )
21 Feb 2011

Changing the paradigm in frontline CML therapy

Prof Giuseppe Saglio - University of Turin, Italy; Dr Delphine Rea - Saint Louis Hospital, Paris; Jan Geissler - Co-Founder, CML Advocates Network
Changing the paradigm in frontline CML therapy ( Prof Giuseppe Saglio - University of Turin, Italy; Dr Delphine Rea - Saint Louis Hospital, Paris; Jan Geissler - Co-Founder, CML Advocates Network )
21 Feb 2011

ENESTnd trial comparing nilotinib and imatinib as first line CML therapy

Prof Timothy Hughes - Institute of Medical and Veterinary Science, Adelaide, Australia
ENESTnd trial comparing nilotinib and imatinib as first line CML therapy ( Prof Timothy Hughes - Institute of Medical and Veterinary Science, Adelaide, Australia )
18 Feb 2011

Haematological cancers in the elderly

Dr Reinhard Stauder - Innsbruck Medical University, Innsbruck, Austria
Haematological cancers in the elderly ( Dr Reinhard Stauder - Innsbruck Medical University, Innsbruck, Austria )
18 Feb 2011

The importance of myelodysplastic syndrome diagnosis

Dr Reinhard Stauder - Innsbruck Medical University, Innsbruck, Austria
The importance of myelodysplastic syndrome diagnosis ( Dr Reinhard Stauder - Innsbruck Medical University, Innsbruck, Austria )
18 Feb 2011

Key lymphoma research from ASH 2010

Prof Wyndham Wilson - National Cancer Institute, Maryland, USA
Key lymphoma research from ASH 2010 ( Prof Wyndham Wilson - National Cancer Institute, Maryland, USA )
18 Feb 2011

The DASISION chronic myeloid leukaemia trial

Dr Neil Shah - University of California, San Francisco, USA
The DASISION chronic myeloid leukaemia trial ( Dr Neil Shah - University of California, San Francisco, USA )
18 Feb 2011

CLL related research from ASH 2010

Dr Michael Keating- MD Anderson Cancer Center, Texas, USA
CLL related research from ASH 2010 ( Dr Michael Keating- MD Anderson Cancer Center, Texas, USA )
18 Feb 2011

Key multiple myeloma research from ASH 2010

Prof Pieter Sonneveld - Erasmus University Rotterdam, Netherlands
Key multiple myeloma research from ASH 2010 ( Prof Pieter Sonneveld - Erasmus University Rotterdam, Netherlands )
18 Feb 2011

The role of plasma cell biology in multiple myeloma

Dr William Matsui - Sidney Kimmel Comprehensive Cancer Center, Baltimore, USA
The role of plasma cell biology in multiple myeloma ( Dr William Matsui - Sidney Kimmel Comprehensive Cancer Center, Baltimore, USA )
18 Feb 2011